Phytopharm dives on 'comprehensive' Cogane failure in Parkinson's
This article was originally published in Scrip
Executive Summary
Phytopharm's Cogane has comprehensively failed the Phase II CONFIDENT-PD trial for the treatment of early stage Parkinson's disease patients.